Cargando…

Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma

Purpose: It is very important to develop potential molecular associated with oral squamous cell carcinoma (OSCC) malignant transformation and progression. Thus, the aim of our study was to determine the amino acid metabolic characteristics of OSCC patients and test their diagnostic value. Experiment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xi-Hu, Jing, Yue, Wang, Shuai, Ding, Feng, Zhang, Xiao-Xin, Chen, Sheng, Zhang, Lei, Hu, Qin-Gang, Ni, Yan-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174902/ https://www.ncbi.nlm.nih.gov/pubmed/32351881 http://dx.doi.org/10.3389/fonc.2020.00426

Ejemplares similares

Amino acids signatures of distance-related surgical margins of oral squamous cell carcinoma
por: Yang, Xi-Hu, et al.
Publicado: (2019)

Functional Heterogeneity of Reelin in the Oral Squamous Cell Carcinoma Microenvironment
por: Zhang, Xinwen, et al.
Publicado: (2021)

Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma
por: Yang, Kaiying, et al.
Publicado: (2023)

Asparagine Synthetase-Mediated l-Asparagine Metabolism Disorder Promotes the Perineural Invasion of Oral Squamous Cell Carcinoma
por: Fu, Yong, et al.
Publicado: (2021)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

Worst Pattern of Perineural Invasion Redefines the Spatial Localization of Nerves in Oral Squamous Cell Carcinoma
por: Fu, Yong, et al.
Publicado: (2021)

CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint
por: Ding, Zhuang, et al.
Publicado: (2021)

CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets
por: Kashima, Jumpei, et al.
Publicado: (2022)

Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma
por: Zuo, Lihua, et al.
Publicado: (2021)

NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration
por: Xuan, Guangxu, et al.
Publicado: (2022)

Clinical diagnostic value of amino acids in laryngeal squamous cell carcinomas
por: Hu, Shousen, et al.
Publicado: (2023)

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole
por: Freitas, Raíza Dias, et al.
Publicado: (2020)

Lipid Droplet-Related PLIN2 in CD68(+) Tumor-Associated Macrophage of Oral Squamous Cell Carcinoma: Implications for Cancer Prognosis and Immunotherapy
por: He, Yijia, et al.
Publicado: (2022)

Circular RNA Expression in Oral Squamous Cell Carcinoma
por: Wang, Yu-Fan, et al.
Publicado: (2018)

miR-17-5p and miR-4443 Promote Esophageal Squamous Cell Carcinoma Development by Targeting TIMP2
por: Wang, Xiaojun, et al.
Publicado: (2021)

The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma
por: Ding, Meng, et al.
Publicado: (2021)

Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies
por: Fultang, Livingstone, et al.
Publicado: (2021)

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target
por: Zhao, Zonglei, et al.
Publicado: (2023)

Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway
por: Yue, Dongli, et al.
Publicado: (2020)

Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
por: Julius, Peter, et al.
Publicado: (2023)

Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration
por: Deng, Yanhui, et al.
Publicado: (2021)

Is the Depth of Invasion a Marker for Elective Neck Dissection in Early Oral Squamous Cell Carcinoma?
por: Aaboubout, Yassine, et al.
Publicado: (2021)

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway
por: Yue, Dongli, et al.
Publicado: (2022)

Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
por: Long, Zhiping, et al.
Publicado: (2020)

Targeting Genomic Alterations in Squamous Cell Lung Cancer
por: Mantripragada, Kalyan, et al.
Publicado: (2013)

Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
por: Yanagi, Teruki, et al.
Publicado: (2018)

Targeted metabolomics for serum amino acids and acylcarnitines in patients with lung cancer
por: Ni, Junjun, et al.
Publicado: (2019)

Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma
por: Zhou, Ping, et al.
Publicado: (2021)

Long Non-Coding RNA LINC01929 Accelerates Progression of Oral Squamous Cell Carcinoma by Targeting the miR-137-3p/FOXC1 Axis
por: Che, Hongze, et al.
Publicado: (2021)

Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
por: Yang, Zhan, et al.
Publicado: (2021)

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma
por: Chen, Fu-Bo, et al.
Publicado: (2020)

CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma
por: Zhou, Suna, et al.
Publicado: (2020)

p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma
por: Yang, Xi-Hu, et al.
Publicado: (2019)

Evaluation of Metabolomics as Diagnostic Targets in Oral Squamous Cell Carcinoma: A Systematic Review
por: Alapati, Susanth, et al.
Publicado: (2023)

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
por: Astolfi, Annalisa, et al.
Publicado: (2020)

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma
por: Jing, Yue, et al.
Publicado: (2019)

Heat Shock Protein 27 (HSP27) as a Potential Prognostic Marker: Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma
por: Ramalingam, Karthikeyan, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

miR-146a Overexpression in Oral Squamous Cell Carcinoma Potentiates Cancer Cell Migration and Invasion Possibly via Targeting HTT
por: Wang, Liping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o9ov6mb13nftd3fto0tthdf7jg